Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS).

Source:http://linkedlifedata.com/resource/pubmed/id/18042591

Download in:

View as

General Info

PMID
18042591